Robert Petryka
- Genetics top 5%
- Immunology top 10%
- Epidemiology
- Oncology
- Rheumatology top 10%
- Co-authors
- Stefan SchreiberSéverine VermeireMaria Wiśniewska‐JarosińskaAnnegret Van der AaXavier RoblinAdrian GoldișMaria KłopockaTanja Kuehbacher
- Topics
- Inflammatory Bowel Disease (12 papers)Chronic Lymphocytic Leukemia Research (5 papers)Microscopic Colitis (3 papers)
- Cited by
- GeneticsImmunologyHematology
- Journals
- The LancetGastroenterologyPLoS ONE
In The Last Decade
Robert Petryka
13 papers receiving 588 citations
Hit Papers
Peers
Comparison fields: 5 of 55
- Genetics 382
- Immunology 239
- Epidemiology 223
- Oncology 127
- Rheumatology 99
Countries citing papers authored by Robert Petryka
This map shows the geographic impact of Robert Petryka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Petryka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Petryka more than expected).
Fields of papers citing papers by Robert Petryka
This network shows the impact of papers produced by Robert Petryka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Petryka. The network helps show where Robert Petryka may publish in the future.
Co-authorship network of co-authors of Robert Petryka
This figure shows the co-authorship network connecting the top 25 collaborators of Robert Petryka. A scholar is included among the top collaborators of Robert Petryka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Petryka. Robert Petryka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 27 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 60 | |
| 5 | Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trialbreakdown → | 344 |
| 6 | 34 | |
| 7 | 2 | |
| 8 | 9 | |
| 9 | 1 | |
| 10 | 1 | |
| 11 | 4 | |
| 12 | 110 | |
| 13 | 1 |
About Robert Petryka
Robert Petryka is a scholar working on Genetics, Genetics and Hematology, having authored 13 papers that have together received 595 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (12 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Microscopic Colitis (3 papers). The work is most often cited by research in Genetics (382 citations), Immunology (239 citations) and Hematology (95 citations). Robert Petryka has collaborated with scholars based in Poland, Germany and France. Frequent co-authors include Stefan Schreiber, Séverine Vermeire, Maria Wiśniewska‐Jarosińska, Annegret Van der Aa, Xavier Roblin, Adrian Goldiș, Maria Kłopocka, Tanja Kuehbacher, Róbert Sike and Pille Harrison. Their work appears in journals such as The Lancet, Gastroenterology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.